Efficacy and safety of Mim8 prophylaxis in adults and adolescents with hemophilia A with or without inhibitors: Phase 3, open-label, randomized, controlled FRONTIER2 study

June 23, 2024 | Maria Elisa Mancuso M.D., Ph.D.; IRCCS Humanitas Research Hospital; Rozzano, Milan, Italy

RSS
1234